• 544 Citations
  • 13 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Salvatore Tafuto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles
Neuroendocrine Tumors Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Italy Medicine & Life Sciences
Somatostatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 544 Citations
  • 13 h-Index
  • 56 Article
  • 5 Review article
Open Access
Colorectal Neoplasms
Therapeutics
aflibercept
Bevacizumab
Survival
3 Citations (Scopus)

Lenvatinib, a molecule with versatile application: From preclinical evidence to future development in anti-cancer treatment

On behalf of ENETs (European NeuroEndocrine Tumor Society) Center of Excellence of Naples, Italy, Jan 1 2019, In : Cancer Management and Research. 11, p. 3847-3860 14 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Thyroid Neoplasms
Receptor, Fibroblast Growth Factor, Type 3
Therapeutics
Vascular Endothelial Growth Factor Receptor

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations

Itanet (Italian Association for Neuroendocrine Tumours), Jan 1 2019, (Accepted/In press) In : Pancreatology.

Research output: Contribution to journalArticle

Tumor Burden
Neoplasms
Liver
Neoplasm Metastasis
Bone and Bones

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Tafuto, S., von Arx, C., Capozzi, M., Tatangelo, F., Mura, M., Modica, R., Barretta, M. L., Di Sarno, A., Tornesello, M. L., Colao, A. & Ottaiano, A., Aug 15 2019, In : Journal of Clinical Medicine. 8, 8

Research output: Contribution to journalArticle

temozolomide
Safety
Neoplasms
Therapeutics
Dacarbazine